# RECLAIM Adaptive Platform Trial for PCC Treatments

> **NCT07280572** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Janneke van de Wijgert** · enrollment: 1250 (estimated)

## Conditions studied

- Post COVID Condition

## Interventions

- **DRUG:** Metformin
- **DRUG:** colchicine

## Key facts

- **NCT ID:** NCT07280572
- **Lead sponsor:** Janneke van de Wijgert
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-02-17
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 1250 (ESTIMATED)
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07280572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07280572, "RECLAIM Adaptive Platform Trial for PCC Treatments". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07280572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*